Joshua J Matacotta1, Francisco J Rosales-Perez2, Christian M Carrillo3. 1. College of Health Sciences, Western University of Health Sciences, Pomona, CA. 2. Department of Behavioral Sciences, Integrative Behavioral Health Research Institute, Pasadena, CA. 3. Pasadena City College, Pasadena, CA.
Abstract
PURPOSE: While the annual rate of new HIV infections and diagnoses has remained stable for most groups, troubling increases are seen in transgender women and racial/ethnic-minority men who have sex with men (MSM), groups that are disproportionately affected by HIV. The primary purpose of this systematic review is to examine factors that impact attitudes and beliefs about preexposure prophylaxis (PrEP) and treatment as prevention (TasP) and to explore barriers to PrEP uptake in MSM and transgender women. METHODS: Using MeSH terms and relevant keywords, we conducted a systematic review of studies published between 2010 and 2019. We searched 4 literature databases and identified studies on MSM and transgender women to elucidate perceptions of PrEP and TasP as well as barriers to access. RESULTS: The search yielded several prominent themes associated with beliefs about HIV prevention approaches and barriers to PrEP access in MSM and transgender women. One was a lack of awareness or insufficient knowledge of PrEP and TasP. Structural barriers and geographic isolation also prevent access to HIV prevention. Sexual minority and HIV-related stigma, internalized homonegativity, and misinterpretations of messages within HIV prevention campaigns have negatively impacted PrEP uptake and beliefs about PrEP and TasP. Quality of the relationship MSM or transgender people have with their health care provider can facilitate or hinder HIV prevention. Finally, variability in beliefs about the efficacy of TasP has negatively affected the impact of TasP messaging campaigns. CONCLUSIONS: Although there is evidence of increasing PrEP use in at-risk individuals, several barriers prevent wider acceptance and uptake. Misunderstanding about the meaning of "undetectable" and skepticism about the evidence behind TasP messaging campaigns are likely to delay the World Health Organization's stated goal of getting to zero transmissions.
PURPOSE: While the annual rate of new HIV infections and diagnoses has remained stable for most groups, troubling increases are seen in transgender women and racial/ethnic-minority men who have sex with men (MSM), groups that are disproportionately affected by HIV. The primary purpose of this systematic review is to examine factors that impact attitudes and beliefs about preexposure prophylaxis (PrEP) and treatment as prevention (TasP) and to explore barriers to PrEP uptake in MSM and transgender women. METHODS: Using MeSH terms and relevant keywords, we conducted a systematic review of studies published between 2010 and 2019. We searched 4 literature databases and identified studies on MSM and transgender women to elucidate perceptions of PrEP and TasP as well as barriers to access. RESULTS: The search yielded several prominent themes associated with beliefs about HIV prevention approaches and barriers to PrEP access in MSM and transgender women. One was a lack of awareness or insufficient knowledge of PrEP and TasP. Structural barriers and geographic isolation also prevent access to HIV prevention. Sexual minority and HIV-related stigma, internalized homonegativity, and misinterpretations of messages within HIV prevention campaigns have negatively impacted PrEP uptake and beliefs about PrEP and TasP. Quality of the relationship MSM or transgender people have with their health care provider can facilitate or hinder HIV prevention. Finally, variability in beliefs about the efficacy of TasP has negatively affected the impact of TasP messaging campaigns. CONCLUSIONS: Although there is evidence of increasing PrEP use in at-risk individuals, several barriers prevent wider acceptance and uptake. Misunderstanding about the meaning of "undetectable" and skepticism about the evidence behind TasP messaging campaigns are likely to delay the World Health Organization's stated goal of getting to zero transmissions.
Authors: Matthew Garnett; Yael Hirsch-Moverman; Julie Franks; Eleanor Hayes-Larson; Wafaa M El-Sadr; Sharon Mannheimer Journal: AIDS Care Date: 2017-08-09
Authors: Matt G Mutchler; Bryce McDavitt; Mansur A Ghani; Kelsey Nogg; Terrell J A Winder; Juliana K Soto Journal: AIDS Patient Care STDS Date: 2015-06-29 Impact factor: 5.078
Authors: Jonathan Garcia; Caroline Parker; Richard G Parker; Patrick A Wilson; Morgan Philbin; Jennifer S Hirsch Journal: Health Educ Behav Date: 2015-08-26
Authors: Michael T LeVasseur; Neal D Goldstein; Loni P Tabb; Brianne L Olivieri-Mui; Seth L Welles Journal: J Acquir Immune Defic Syndr Date: 2018-01-01 Impact factor: 3.731
Authors: Ian W Holloway; Ryan Dougherty; Jennifer Gildner; Sean C Beougher; Craig Pulsipher; Jorge A Montoya; Aaron Plant; Arleen Leibowitz Journal: J Acquir Immune Defic Syndr Date: 2017-01-01 Impact factor: 3.771
Authors: William C Goedel; Maximilian R F King; Mark N Lurie; Amy S Nunn; Philip A Chan; Brandon D L Marshall Journal: J Acquir Immune Defic Syndr Date: 2018-11-01 Impact factor: 3.771
Authors: Ian W Holloway; Diane Tan; Jennifer L Gildner; Sean C Beougher; Craig Pulsipher; Jorge A Montoya; Aaron Plant; Arleen Leibowitz Journal: AIDS Patient Care STDS Date: 2017-12 Impact factor: 5.944
Authors: Priscila Lutete; David W Matthews; Nasim S Sabounchi; Mark Q Paige; David W Lounsbury; Noah Rodriguez; Natalie Echevarria; DaShawn Usher; Julian J Walker; Alexis Dickerson; Joseph Hillesheim; Victoria Frye Journal: Am J Public Health Date: 2022-06 Impact factor: 11.561
Authors: Lila Starbuck; Sarit A Golub; Augustus Klein; Alexander B Harris; Amiyah Guerra; Christopher Rincon; Asa E Radix Journal: J Acquir Immune Defic Syndr Date: 2022-05-01 Impact factor: 3.771
Authors: John Mark Wiginton; Sarah M Murray; Jura Augustinavicius; Jessica L Maksut; Bridget J Anderson; Kwa Sey; Yingbo Ma; Colin P Flynn; Danielle German; Emily Higgins; Timothy W Menza; E Roberto Orellana; Anna B Flynn; Alia Al-Tayyib; Jennifer Kienzle; Garrett Shields; Zaida Lopez; Paige Wermuth; Stefan D Baral Journal: Am J Epidemiol Date: 2022-01-01 Impact factor: 5.363
Authors: Lilli Mann-Jackson; Jorge Alonzo; Manuel Garcia; Scott Trent; Jonathan Bell; Danielle N Horridge; Scott D Rhodes Journal: Health Soc Care Community Date: 2020-12-28
Authors: Rachel A Fikslin; Alison J Goldberg; Amanda N Gesselman; Mora A Reinka; Omaima Pervez; Elissia T Franklin; Olivia Ahn; Devon M Price Journal: Arch Sex Behav Date: 2021-11-08
Authors: Susanne Hempel; Laura Ferguson; Maria Bolshakova; Sachi Yagyu; Ning Fu; Aneesa Motala; Sofia Gruskin Journal: BMJ Open Date: 2021-12-09 Impact factor: 3.006
Authors: Jennifer K Felner; Maria L Mittal; Martin Hoenigl; K Rivet Amico; David J Grelotti; Alex Eanes; Kristen Hess; Jessica Crawford; Laramie R Smith Journal: J Acquir Immune Defic Syndr Date: 2021-04-15 Impact factor: 3.771
Authors: Kimberly A Koester; Xavier A Erguera; Ifeoma Udoh; Mi-Suk Kang Dufour; Jeffrey H Burack; Janet J Myers Journal: Front Public Health Date: 2021-12-07